Results 191 to 200 of about 37,987 (275)

Sex Differences in Response and Persistence to Biologic Therapy in Psoriatic Arthritis: A 52‐Week Analysis With Extended Long‐Term Outcomes

The Journal of Dermatology, Volume 53, Issue 2, Page 219-230, February 2026.
ABSTRACT Psoriatic arthritis (PsA) is a chronic immune‐mediated disease with heterogeneous joint and skin manifestations. Although biologic therapies targeting TNFα, IL‐17, and IL‐23 have transformed PsA management, sex‐specific differences in efficacy and treatment persistence remain underexplored.
Keita Ohyachi, Saori Takamura, Kanade Iino, Souichiro Saito, Mizuki Takeuchi, Tomoo Fukuda   +5 more
wiley   +1 more source

Real‐World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP)

The Journal of Dermatology, Volume 53, Issue 2, Page 351-356, February 2026.
ABSTRACT Generalized pustular psoriasis (GPP) is a heterogeneous, systemic neutrophilic inflammatory disease, characterized by chronic symptoms and recurrent flares, which can be potentially life‐threatening. Spesolimab, an interleukin‐36 receptor antagonist, has been approved to treat GPP flares in many countries including Japan.
Akimichi Morita, Yayoi Tada, Yuichiro Tsunemi, Mayumi Komine, Takuro Kanekura, Shinichi Imafuku, Toshiya Takahashi, Xuemei Ding, Nichiren Pillai, Morihisa Saitoh, Rafael Sani Simoes, Nora Pöntynen, Keiichi Yamanaka   +12 more
wiley   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Edward Carmona, Plaintiff-Appellant v. Southwest Airlines Company, Defendant-Appellee [PDF]

, 2010
Garwood, Judge Will
core   +1 more source

Therapeutic Windows Across the Psoriatic Arthritis Spectrum. [PDF]

Rheumatol Ther
Kang JH, Coates LC.
europepmc   +1 more source

Tocilizumab-induced psoriatic dermatitis in polyarticular juvenile idiopathic arthritis: A rare case report. [PDF]

SAGE Open Med Case Rep
Rajesh RY, Biju Seena P, Nakhutsrishvili E, Akkineni T, Ahmed AA, Suvvari TK, Thomas V, Singh T.   +7 more
europepmc   +1 more source

Psoriatic Arthritis: Developments in 2025. [PDF]

Mediterr J Rheumatol
Spanopoulou C, Katsimbri P.
europepmc   +1 more source

Systemic Treatment Strategies for Patients with Psoriasis and Psoriatic Arthritis in the Setting of ANA Positivity or Lupus Spectrum Disease: A Comprehensive Systematic Review. [PDF]

Int J Mol Sci
Tjiu JW, Tsai TF.
europepmc   +1 more source

Atypical, polyarticular lipoma arborescens in a child [PDF]

, 2016
Adjić, Oto, Djuričić, Slaviša, Semnic, Robert, Simić, Radoje, Vanhoenacker, Filip   +4 more
core   +1 more source

Psoriatic Arthritis: From Diagnosis to Treatment. [PDF]

J Clin Med
Kannappan R, Kim S, Lau A, Brent LH.
europepmc   +1 more source